Comprehensive Analysis of CXCL genes in Human Kidney Clear Cell Carcinoma

Introduction: the predictive value for survival outcomes and mechanisms of the CXCL gene family in kidney Clear Cell Carcinoma (KIRC). Objective: We evaluated the predictive value for survival outcomes and mechanisms of the CXCL gene family in Kidney Clear Cell Carcinoma (KIRC). Methods: Transcriptional and survival data of CXCL genes in KIRC patients were retrieved from Oncomine and GEPIA databases to assess their functions. Mutations’ data were downloaded from the cBioPortal, while immune cell components data were obtained from TIMER databases. Enrichment analysis was performed using the STRING database. In vitro assays were performed to validate our findings. Results: A total of 8 CXCL (CXCL2/5/9/10/11/12/13/16) genes were found to be differentially expressed in KIRC tissues. Among them, only CXCL2 and CXCL5 had survival values. In vitro assays revealed that upregulated CXCL2 promotes renal cancer cell proliferation, migration and invasion. Additionally, CXCL2 exhibited an effect on three KIRC immune cell components (B cells, CD4 T cells, and Neutrophils). After evaluating the miRNA sequences upstream of CXCL2, it was established that hsa-miR-532-5p/CXCL2 pathways are potentially involved in the regulatory mechanisms. Finally, we established a prospective signature (CXCL1/5/13) for improved survival outcomes among KIRC patients. Conclusion: Among KIRC patients, 8 CXCL genes were differentially expressed, however, only CXCL2 and CXCL5 exhibited a significant survival value. Upregulated CXCL2 promotes renal cancer cell progression.